Sri Sriadibhatla, Ph.D.
Investment Director, Health Investment Group
Sri Sriadibhatla, Ph.D. is Investment Director, Health
Investment Group and principle support for life sciences programs. Sri manages the Technology Acceleration Fund (TAF) loan program in the Health & Digital Health Sector. He has over twelve years of experience in technology evaluation, licensing, investment and commercialization.
Prior to joining Ben Franklin, Sri was Technology Scout at FMC Corporation and led initiatives in developing, adapting, streamlining, and executing an Open Innovation model. Sri holds a PhD in Pharmaceutical Sciences (Center for Drug Delivery and Nanomedicine) from the University of Nebraska Medical Center.